1. News from ASH 2018—how can we afford innovation in the future?

   • Dominik Wolf

   editorial 26 September 2019 Pages: 189 - 190

2. Immunosuppression and its complications

   • Eberhard Gunsilius

   editorial 26 September 2019 Pages: 191 - 191

3. Screening and prophylaxis of cancer

   • Holger Rumpold

   editorial 26 September 2019 Pages: 192 - 193

4. Post San Antonio

   • Kathrin Strasser-Weippl

   editorial 26 September 2019 Pages: 194 - 195

5. CML at the 2018 ASH meeting—selected presentations

   • Stefan Schmidt

   short review 20 September 2019 Pages: 196 - 199

6. Highlights on chronic lymphocytic leukemia presented at the 2018 American Society of Hematology Meeting

   • Daniel Heintel

   special report 17 September 2019 Pages: 200 - 202

7. ASH 2018—Highlights in Multiple Myeloma

   • Georg Jeryczynski
   • Maria-Theresa Krauth

   short review Open access 12 August 2019 Pages: 203 - 206

8. ASH 2018—aggressive lymphoma

   • Michael Panny

   short review 30 July 2019 Pages: 207 - 211

   

9. Update in thrombosis and hemostasis: ASH meeting 2018

   • Clemens Feistritzer

   short review Open access 17 May 2019 Pages: 212 - 215

10. Immunosuppression after renal transplantation

    • Hannes Neuwirt
    • Michael Rudnicki
    • Gert Mayer

    review Open access 10 July 2019 Pages: 216 - 221

11. Skin tumours in organ transplant recipients—implications for the plastic surgeon

    • Johanna Krapf
    • Gerhard Pierer

    short review 01 July 2019 Pages: 222 - 224

12. Risk of cancer after long-term therapy of autoimmune disorders with glucocorticoids or DMARDs—a controversial issue

    • Jakob D. Rudzki

    short review Open access 12 July 2019 Pages: 225 - 229

13. HIV-triggered lymphoma

    • Bernd Lorenz Hartmann
    • Michèle Desiré Atzl

    short review 15 August 2019 Pages: 230 - 234

14. Cutaneous melanoma—The benefit of screening and preventive measures

    • Magdalena Seidl-Philipp
    • Van Anh Nguyen

    short review 25 July 2019 Pages: 235 - 238

    

15. Colorectal cancer screening and prevention—pros and cons

    • Markus Niederreiter
    • Lukas Niederreiter
    • Angela Djanani

    short review Open access 13 September 2019 Pages: 239 - 243

16. PSA screening—a matter of debate?

    • Isabel Heidegger

    review Open access 28 August 2019 Pages: 244 - 248

17. Checkpoint inhibitors in head and neck cancer

    • Ilson Sepulveda
    • Rodrigo Ascui
    • A. Andrés Capizzano

    short review 17 July 2019 Pages: 249 - 252

18. Systemic treatment of metastatic breast cancer: SABCS 2018

    • Theresa Westphal
    • Simon Peter Gampenrieder
    • Richard Greil

    short review Open access 15 August 2019 Pages: 253 - 256

19. Post San Antonio Breast Cancer Symposium 2018

    • Ruth Exner

    short review Open access 25 July 2019 Pages: 257 - 260

    

20. Post San Antonio: immunotherapy, chemotherapy and new combinations

    • Karl Mayrhofer
    • Kathrin Strasser-Weippl

    short review 16 July 2019 Pages: 261 - 264

21. Cure is not enough! Why it is time to act and close the gap

    • Carina Schneider
    • Jaap den Hartogh
    • CCI Europe

    short review 02 August 2019 Pages: 265 - 268

22. A wearable cardioverter defibrillator for prevention of sudden cardiac death in a hematologic patient—a case report

    • Stefan Hatzl
    • Hildegard T. Greinix
    • Daniel Scherr

    case report Open access 07 August 2019 Pages: 269 - 271

    

23. Immunotherapeutic approach to a case of advanced hepatoid adenocarcinoma of the lung

    • Anthony El Khoury
    • Marc El Khoury
    • Russel De Luca

    case report Open access 12 June 2019 Pages: 272 - 277

24. Head and neck Langerhans cell histiocytosis: two case reports and review of the literature

    • Ilson Sepúlveda
    • Ignacio Mendoza
    • Francisco Rivas-Rodriguez

    case report 12 June 2019 Pages: 278 - 283